Article
Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer.
Molecular cancer therapeutics - 1 Jul 2017
Chae Young Kwang, Davis Andrew A, Jain Sarika, Santa-Maria Cesar, Flaum Lisa, Beaubier Nike, Platanias Leonidas C, Gradishar William, Giles Francis J, Cristofanilli Massimo
Abstract excerpt
While identifying genomic alterations in tumor tissue is the current gold-standard technique for molecular profiling, circulating tumor DNA (ctDNA) represents a noninvasive method of assessing genomic alterations using peripheral blood. The concordance of genomic alterations between two commercially available ctDNA and tissue biopsies was compared in 45 patients with breast cancer using paired next-generation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
